{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:47:14Z","timestamp":1794019634256,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004689","name":"Consejo de Desarrollo Cient\u00c3\u00adfico, Human\u00c3\u00adstico y Tecnol\u00c3\u00b3gico, Universidad del Zulia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009943","name":"Universidad Central de Venezuela","doi-asserted-by":"publisher","award":["PG-03-8289-2011\/1"],"award-info":[{"award-number":["PG-03-8289-2011\/1"]}],"id":[{"id":"10.13039\/501100009943","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009943","name":"Universidad Central de Venezuela","doi-asserted-by":"publisher","award":["PG 03-8728-2013\/2"],"award-info":[{"award-number":["PG 03-8728-2013\/2"]}],"id":[{"id":"10.13039\/501100009943","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009613","name":"Centro de Investigaciones Energ\u00c3\u00a9ticas, Medioambientales y Tecnol\u00c3\u00b3gicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009613","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007708","name":"Fondo Nacional de Ciencia Tecnolog\u00c3\u00ada e Innovaci\u00c3\u00b3n","doi-asserted-by":"publisher","award":["2017000274"],"award-info":[{"award-number":["2017000274"]}],"id":[{"id":"10.13039\/501100007708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.actatropica.2018.03.023","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T13:01:38Z","timestamp":1522242098000},"page":"36-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption"],"prefix":"10.1016","volume":"183","author":[{"given":"Elizabeth","family":"Valdivieso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Mej\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Torrealba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Benaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir V.","family":"Kouznetsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Sojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando A.","family":"Rojas-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Arvelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francehuli","family":"Dagger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2018.03.023_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0065-308X(05)61006-8","article-title":"Chemotherapy in the treatment and control of leishmaniasis","volume":"61","author":"Alvar","year":"2006","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0010","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2018.03.023_bib0015","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1128\/AAC.01240-13","article-title":"Dronedarone, an amiodarone analog with improved anti-Leishmania mexicana efficacy","volume":"58","author":"Benaim","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0020","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1016\/j.bmc.2013.04.063","article-title":"Anti-leishmanial evaluation of C2-aryl quinolines: mechanistic insight on bioenergetics and sterol biosynthetic pathway of Leishmania braziliensis","volume":"15","author":"Bompart","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0025","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/157018012799079761","article-title":"In vitro antimycobacterial activity of new 7-chloroquinoline derivatives","volume":"9","author":"Bueno","year":"2012","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0030","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1128\/AAC.00790-10","article-title":"Tafenoquine, an antiplasmodial 8-aminoquinoline, targets leishmania respiratory complex III and induces apoptosis","volume":"54","author":"Carvalho","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0035","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1128\/AAC.00520-11","article-title":"The 8-aminoquinolines analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase","volume":"42","author":"Carvalho","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0040","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1128\/AAC.45.7.2023-2029.2001","article-title":"Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones","volume":"45","author":"Chen","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0035-9203(90)90263-E","article-title":"Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate","volume":"84","author":"Chunge","year":"1990","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0050","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0960-894X(00)00122-0","article-title":"New quinolinic derivatives as centrally active antioxidants","volume":"10","author":"Dorey","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0055","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bmcl.2013.12.071","article-title":"In vitro phenotypic screening of 7-chloro-4-amino(oxy)quinoline derivatives as putative anti-Trypanosoma cruzi agents","volume":"24","author":"Fonseca-Berzal","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0060","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1128\/AAC.22.5.743","article-title":"Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method","volume":"22","author":"Hallander","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0065","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.4269\/ajtmh.2005.73.1005","article-title":"A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India","volume":"73","author":"Jha","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157018007784620031","article-title":"Target-oriented synthesis of antiparasitic 2-hetaryl substituted quinolines based on imino Diels-Alder reactions","volume":"4","author":"Kouznetsov","year":"2007","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0075","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1007\/s00044-016-1688-6","article-title":"Synthesis and cytotoxic evaluation of 7-chloro-4-phenoxyquinolines with formyl, oxime and thiosemicarbazone scaffolds","volume":"25","author":"Kouznetsov","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0080","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1128\/AAC.01415-06","article-title":"Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes","volume":"51","author":"Luque-Ortega","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0085","doi-asserted-by":"crossref","first-page":"30684","DOI":"10.1074\/jbc.M204353200","article-title":"Mechanism of apoptosis induced by a new topoisomerase inhibitor through the generation of hydrogen peroxide","volume":"277","author":"Mizutani","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.actatropica.2018.03.023_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2005.08.016","article-title":"Roles for mitochondria in pentamidine susceptibility and resistance in Leishmania donovani","volume":"145","author":"Mukherjee","year":"2006","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jac\/35.5.577","article-title":"The sensitivity of Leishmania species to aminosidine","volume":"35","author":"Neal","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0110","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jinf.2014.07.016","article-title":"Leishmaniasis","volume":"69","author":"Pace","year":"2014","journal-title":"J. Infect."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01614-17","article-title":"Mechanism of action of miltefosine on Leishmania donovani involves the impairment of acidocalcisome function and the activation of the sphingosine-dependent plasma membrane Ca2+ channel","volume":"62","author":"Pinto-Martinez","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0120","first-page":"277","article-title":"Leishmaniasis: drug resistance and natural products","volume":"22","author":"Polonio","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0125","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/1389557511313050010","article-title":"Quinolines as chemotherapeutic agents for leishmaniasis","volume":"13","author":"Reynolds","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0130","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cbpa.2010.03.023","article-title":"New antileishmanial candidates and lead compounds","volume":"14","author":"Richard","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","article-title":"In vitro and in vivo interactions between miltefosine and other antileishmanial drugs","volume":"50","author":"Seifert","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0140","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1093\/jac\/dkq542","article-title":"In vitro interactions between simaquine and amphotericin B, sodium stibogluconate, miltefosine, paromomycin and pentamidine against Leishmania donovani","volume":"66","author":"Seifert","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0145","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bmcl.2013.11.018","article-title":"Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents","volume":"24","author":"Sharma","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0150","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1995-7645(12)60084-4","article-title":"Leishmaniasis: current status ofavailable drugs and new potential drug targets","volume":"5","author":"Singh","year":"2012","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1517\/14656566.2015.973850","article-title":"An update on pharmacotherapy for leishmaniasis","volume":"16","author":"Sundar","year":"2015","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0160","first-page":"98","article-title":"Recent developments and future prospects in the treatment of visceral leishmaniasis","volume":"3","author":"Sundar","year":"2016","journal-title":"Ther. Adv. Infect. Dis."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0165","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/QCO.0b013e328010b848","article-title":"8-Aminoquinolines: future role as antiprotozoal drugs","volume":"19","author":"Tekwani","year":"2006","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0170","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1128\/AAC.49.3.1076-1080.2005","article-title":"Synthesis and antileishmanial activities of novel 3-subtituted quinolines","volume":"49","author":"Tempone","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0175","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"Van Griensven","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0180","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1016\/j.bmc.2004.03.045","article-title":"Ring- substituted quinolines as a potential anti-tuberculosis agent","volume":"12","author":"Vangadapus","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0185","series-title":"Control of the Leishmaniasis. Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases. WHO Technical Report Series 949","author":"WHO","year":"2010"},{"key":"10.1016\/j.actatropica.2018.03.023_bib0190","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4269\/ajtmh.2005.73.871","article-title":"A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya","volume":"73","author":"Wasunna","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2018.03.023_bib0195","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.drudis.2017.06.004","article-title":"Leishmaniasis drug discovery: recent progress and challenges in assay development","volume":"22","author":"Zulfiqar","year":"2017","journal-title":"Drug Discov. Today"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X18300160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X18300160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:11:23Z","timestamp":1757549483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X18300160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":39,"alternative-id":["S0001706X18300160"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2018.03.023","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2018.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}